Ledger.Open graph →
SEC Form D · filed November 27, 2023

Alto Neuroscience, Inc

Offering
$45.0M
Sold
$45.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LOS ALTOS, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Andrew N. Dreyfus · Los Altos, CADirectorAaron Weaver · Los Altos, CADirectorAdam Savitz · Los Altos, CAExecPo Yu (Jeff) Chen · Los Altos, CADirectorAmit Etkin · Los Altos, CAExec · DirectorNicholas Smith · Los Altos, CAExecChris N. Dimitropoulos · Los Altos, CADirectorMichael N. Liang · Los Altos, CADirectorChristopher N. Cox · Los Altos, CADirectorGwill York · Los Altos, CADirectorAaron Weaver · Los Altos, CADirectorGwill York · Los Altos, CADirectorAmit Etkin · Los Altos, CAExec · DirectorChris N. Dimitropoulos · Los Altos, CADirectorChristopher N. Cox · Los Altos, CADirectorPo Yu (Jeff) Chen · Los Altos, CADirectorNicholas Smith · Los Altos, CAExecAdam Savitz · Los Altos, CAExecMichael N. Liang · Los Altos, CADirectorAndrew N. Dreyfus · Los Altos, CADirectorMichael E. Iszygon · Houston, TXDirectorChristopher G. Dupont · Houston, TXExecAbbasi N. Dhilawala · Houston, TXDirectorJesse Hutcher · New York, NYDirectorBrandon Laxton · Prosper, TXDirectorGregory Frankel · Miami, FLExec · DirectorMarc Singer · Miami, FLDirectorCardona D. Lee · Guaynabo, Puerto RicoDirectorJeffrey S. Mason · Vista, CAExecKomathi S. Stem · Littleton, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗